Central Neurocytoma Treated Using Supratentorial Ventricle Radiotherapy: A Single-Institution Analysis of Five Cases in Adjuvant or Salvage Settings After Surgery.

Takeshi Maemura, Atsuto Katano, Hirokazu Takami, Masashi Nomura, Shunsaku Takayanagi, Hideomi Yamashita

Abstract read

In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

Extraventricular Neurocytoma With a Complex Presentation: The Role of Molecular Studies and Technology in Its Management.Cureus · 2025
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Takeshi MaemuraDepartment of Radiology, The University of Tokyo Hospital, Tokyo, JPN.

Atsuto KatanoDepartment of Radiology, The University of Tokyo Hospital, Tokyo, JPN.

Hirokazu TakamiDepartment of Neurosurgery, The University of Tokyo Hospital, Tokyo, JPN.

Masashi NomuraDepartment of Neurosurgery, The University of Tokyo Hospital, Tokyo, JPN.

Shunsaku TakayanagiDepartment of Neurosurgery, The University of Tokyo Hospital, Tokyo, JPN.

Hideomi YamashitaDepartment of Radiology, The University of Tokyo Hospital, Tokyo, JPN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionCentral neurocytoma (CN) is an extremely rare tumor primarily located in the supratentorial ventricular system, categorized as a glioneuronal or neuronal tumor.

methodsThis study presented a retrospective analysis of five CN patients who received adjuvant or salvage radiotherapy. Patients, aged 31-59 years, underwent radiation doses ranging from 60 Gy to 50.4 Gy over 27-30 fractions.

resultsAll patients achieved effective local tumor control without severe complications. The median follow-up period was 51.7 months, demonstrating 100% overall and progression-free survival rates. DISCUSSION: Our study's clinical outcomes align with previous research, despite the limitation of a small sample size. Emphasizing the necessity for additional research, our findings added to the potential evidence of radiotherapy in managing CN. Larger, long-term studies were needed to confirm these promising results.

Indexed as

adjuvant therapycentral neurocytomaradiotherapysalvage therapysupratentorial ventricle

Identifiers

PMID38618419

DOI10.7759/cureus.56132

PMCPMC11015110

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.